Executive Summary for The Society of Thoracic Surgeons (STS) / World Society for Pediatric and Congenital Heart

Jennifer S Nelson1, Awais Ashfaq2, James D St Louis3

  • 1Department of Cardiovascular Services, Nemours Children's Hospital, Orlando, Florida, USA.

Insights

Pulmonary valve replacement (PVR) is crucial for repaired Tetralogy of Fallot (TOF) patients. Guidelines now offer an updated framework for PVR timing, considering symptoms, heart function, and risks.

Area of Science:

  • Cardiology
  • Congenital Heart Surgery
  • Pediatric Cardiology

Background:

  • Pulmonary valve replacement (PVR) is a critical intervention for patients with repaired Tetralogy of Fallot (TOF) experiencing significant pulmonary regurgitation.
  • Existing guidelines require an update to reflect current evidence and consensus on PVR timing and indications.

Purpose of the Study:

  • To summarize consensus-based recommendations from three multi-societal documents regarding PVR in repaired TOF.
  • To provide an updated framework for clinical decision-making on PVR timing, indications, and options.

Main Methods:

  • Synthesis of evidence-based Clinical Practice Guidelines (CPG), Expert Consensus Documents (ECD), and Expert Opinion ("White Paper").
  • Collaboration between The Society of Thoracic Surgeons (STS), The World Society for Pediatric and Congenital Heart Surgery (WSPCHS), and The European Congenital Heart Surgeons Association (ECHSA).

Main Results:

  • Key decision-making factors for PVR include symptom status, ventricular volumes and function, and procedural risks.
  • Emerging evidence supports tailored intervention strategies for PVR in repaired TOF patients.

Conclusions:

  • The summarized documents offer a comprehensive framework for PVR decision-making in repaired TOF.
  • Future research should compare transcatheter versus open surgical PVR outcomes, especially in pediatric and adolescent populations.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Valves01:16

Heart Valves

The human heart is a complex organ with an intricate system of valves that regulate blood flow. There are two main types of valves: atrioventricular (AV) valves and semilunar valves.
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...